Hanimune Therapeutics is a startup based in the United States.
Based in the United States, Hanimune Therapeutics is a startup.
Hanimune Therapeutics develops consumer food products aimed at preventing and managing food allergies by delivering controlled doses of common allergens to build tolerance; offerings include 'Lil Mixins' for early infant allergen introduction and 'Top9Proteins' formulations with reliable allergen quantities.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.